HP and coronary artery disorder: The association between Hp phenotype and outcomes after intensified/conventional therapy was investigated in a large randomized controlled trial by Carew et al., who showed that patients with Hp2-2 phenotype who received intensified therapy had less CHD and CVD outcomes, while the intensified treatment brought increased mortality risk for Hp1-1 patients [130].